Renier J. Brentjens, MD, PhD | Authors

Articles

Differences Between NCI, MSKCC, and UPenn CAR-Modified T Cells

January 16, 2014

Renier J. Brentjens, MD, PhD, associate professor, chief, Cellular Therapeutics Center, Memorial Sloan-Kettering Cancer Center, discusses the differences between the CAR-modified T cells of three institutions.